Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaAfamelanotide (Scenesse)

Afamelanotide (Scenesse)

Alpha-MSH analogue

Registered (specialist)

What it is

A melanocortin analogue implant that increases melanin, used to protect skin in a rare light-sensitivity condition.

What the evidence shows

Approved on the basis of clinical evidence for its specific photoprotective indication.

Safety & reported risks

Administered and monitored by specialists within its approved indication.

Status in Australia

A registered medicine for erythropoietic protoporphyria (EPP), accessed through specialist care.

How it’s lawfully accessed

Specialist-led access for its registered indication — not a cosmetic tanning product.

Related peptides

Melanotan IIMelanocortin agonistNot for human usePT-141 (Bremelanotide)Melanocortin agonistNot ARTG-approved

Sources & further reading

This entry is general information about Afamelanotide (Scenesse), not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.